Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.
about
Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factorsFatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaSIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidationSDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domainPPAR delta: a dagger in the heart of the metabolic syndrome.Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewHuman and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamilyIsolation of the human peroxisomal acyl-CoA oxidase gene: organization, promoter analysis, and chromosomal localizationIntegrated physiology and systems biology of PPARαAdipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alphaPPARs and the cardiovascular systemTargeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferatorsRetina-specific nuclear receptor: A potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Müller glial cellsRelationship between PPARalpha activation and NO on proximal tubular Na+ transport in the ratTranscriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell functionAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerUse of fibrates in the metabolic syndrome: A reviewMolecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive MoleculesPPARs: Protectors or Opponents of Myocardial Function?Nuclear Receptors, RXR, and the Big BangNuclear receptors in bone physiology and diseasesRole of Peroxisome Proliferator-Activated Receptor γ in Ocular DiseasesRosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cellsTranscription Adaptation during In Vitro Adipogenesis and Osteogenesis of Porcine Mesenchymal Stem Cells: Dynamics of Pathways, Biological Processes, Up-Stream Regulators, and Gene NetworksPPARβ interprets a chromatin signature of pluripotency to promote embryonic differentiation at gastrulationPip2p: a transcriptional regulator of peroxisome proliferation in the yeast Saccharomyces cerevisiae.The biochemistry of peroxisomal beta-oxidation in the yeast Saccharomyces cerevisiae.Pex11p plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae.PPARγ as a therapeutic target to rescue mitochondrial function in neurological diseaseRegulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPARIdentification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting proteinApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsPeroxisome proliferator-activated receptors in cutaneous biologyThe organization, promoter analysis, and expression of the human PPARgamma geneIsolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptorMechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate
P2860
Q24292462-C10978C8-0974-4F19-ADF1-634DF46DBE85Q24314755-58A2DA07-53D5-4D45-8146-071AA7A6C4C5Q24336468-46B84B51-E6E8-45B9-BEC4-B4DD44F51EB4Q24535573-4FAE71B1-DB70-4D04-8580-821FE9181B2EQ24541527-BEB657E7-95BC-4FCE-8A78-E76336A431E6Q24550862-31EF698E-F65A-4A19-8C99-D6E8C88D9B4BQ24561401-0B305F03-35B7-4576-9B9A-FB817C8C3DA1Q24562455-B369B31F-7E68-43F7-99D4-585E2B68E73DQ24563662-1B3D2CBF-04BD-43AE-9CF5-2415D4E0B012Q24564130-DB3095B8-0B62-4D1C-A797-BD61D34993F2Q24631304-D1072DB3-A3F3-446F-8774-69089BE39E6FQ24642728-21BBE214-3695-4B94-A592-5DD81189DC04Q24652367-2B237735-B781-49AF-8315-4709625F1742Q24655778-10E1F355-B92F-4ABD-A7BC-C0E69A20AFA9Q24799696-A35D6FD8-F0AC-4679-B174-1DABF72FC4F9Q24803245-DBC4103C-30B9-4CAF-B985-758849D00EF1Q24803926-B858EE1B-2AA2-40D0-B094-CA0AFDEAA84CQ26739984-3845A322-C765-408B-B477-AC5EAFE75DBEQ26764921-95B3C0AA-1A3C-44EF-A786-39A908710D30Q26765234-F2FB0E30-A02B-404D-BBBC-61DF8C1E104DQ26770105-5E2D2D55-1F3F-493E-93B1-A1D47CCCCB24Q26771753-FE0F486A-320C-4043-8A6A-4F3EAB777C1FQ26821789-94C54AC8-1EAD-441D-85C7-E85BFFDB3009Q26853017-1169D258-3146-4CB8-9C1B-039CF84656F9Q27022548-26CA4772-6B35-4119-AC17-A3561FBB055EQ27309387-78817FCC-9FB3-49E1-A4FF-DC0A85245FE4Q27318518-21819B47-6C14-4126-9FBC-B6C6B9A1F8BEQ27340116-8A25CB09-9765-4F7D-B3DE-653FC87D405DQ27932690-17399FB2-FE2B-4AF0-B949-7286D1DCCD26Q27933605-071A8557-4FF0-4032-ABA5-999B942DC03EQ27934293-B1865B4C-91C6-408D-8136-89847F4BA3D5Q28069549-2845011B-2343-4DE9-B266-8052394EEACAQ28115776-7845BDEA-7088-4E03-BC43-A396E141C4B2Q28143258-C2BB6953-F3CF-4A18-AB09-EC6613F8B413Q28144400-E971BCA3-0010-44FD-82AA-0001C6477AB6Q28183207-8884E158-03A7-45E4-86E5-D3962CAA63DCQ28202926-D0BE161C-A89E-4699-BC71-FE662BC10AADQ28244071-B1BC7917-8CAC-420E-BB1F-00D7CD0CB595Q28250779-3ACCF0EC-390E-4B08-B792-AC0203FD18CAQ28256111-89E4E67E-F421-48C8-BB4A-CF1F97A9C060
P2860
Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@ast
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@en
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@nl
type
label
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@ast
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@en
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@nl
prefLabel
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@ast
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@en
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@nl
P2093
P1433
P1476
Control of the peroxisomal bet ...... of nuclear hormone receptors.
@en
P2093
P304
P356
10.1016/0092-8674(92)90031-7
P407
P577
1992-03-01T00:00:00Z